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ABSTRACT
Improved approaches and methodologies are needed to
conduct comparative effectiveness research (CER) in
oncology. While cancer therapies continue to emerge at a
rapid pace, the review, synthesis, and dissemination of
evidence-based interventions across clinical trials lag in
comparison. Rigorous and systematic testing of
competing therapies has been clouded by age-old
problems: poor patient adherence, inability to objectively
measure the environmental inﬂuences on health, lack of
knowledge about patients’ lifestyle behaviors that may
affect cancer’s progression and recurrence, and limited
abilitytocompileandinterpretthewiderangeofvariables
thatmustbeconsideredinthecancertreatment.Thislack
of data integration limits the potential for patients and
clinicians to engage in fully informed decision-making
regarding cancer prevention, treatment, and survivorship
care, and the translation of research results into
mainstreammedicalcare.Particularlyimportant,asnoted
in a 2009 report on CER to the President and Congress,
thelimitedfocusonhealthbehavior-changeinterventions
was a major hindrance in this research landscape (DHHS
2009). This paper describes an initiative to improve CER
for cancer by addressing several of these limitations. The
Cyberinfrastructure for Comparative Effectiveness
Research (CYCORE) project, informed by the National
Science Foundation’s2 0 0 7r e p o r t“Cyberinfrastructure
Vision for 21
st Century Discovery” has, as its central aim,
thecreationofaprototypeforauser-friendly,open-source
cyberinfrastructure(CI)thatsupportsacquisition,storage,
visualization, analysis, and sharing of data important for
cancer-relatedCER.Although still under development, the
process of gathering requirements for CYCORE has
revealed new ways in which CI design can signiﬁcantly
improve the collection and analysis of a wide variety of
data types, and has resulted in new and important
partnerships among cancer researchers engaged in
advancing health-related CI.
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Adherence to medical regimens has been
appreciated historically as a key factor that
inﬂuences outcomes of clinical trials in cancer.
Recent data also suggest that lifestyle factors such
as tobacco and alcohol use, physical activity,
dietary consumption, and energy balance may
serve as powerful prognostic indicators of the
outcome of clinical trials as well as long-term
success of cancer treatment [2–7]. Additionally, a
growing body of literature is demonstrating the
impact of environmental factors on disease out-
comes. Even though low-cost and increasingly
ubiquitous technologies support objective meas-
urement in each of these domains—treatment
adherence, health behavior, and continuing envi-
ronmental exposures—these ﬁndings often remain
unaccounted for in comparative effectiveness
research (CER) because of the challenges inherent
in collecting, processing, and acting upon this
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Implications
Practice: Clinicians will ﬁnd decision-making
easier and more effective for the patients
because new variables can be taken into
account, including those arising from individ-
ual differences. A physician can then prescribe
treatment regimens with more conﬁdence of
positive outcomes.
Policy: The information gleaned from better-
supported CER studies can be used to inform
national health policy, and because of
increased effectiveness, can lower the cost of
health care signiﬁcantly for patients, providers
and insurers.
Research: CYCORE facilitates the collection
and analysis of home-based physiological,
behavioral, social and environmental data from
patients undergoing cancer treatment. Largely
either unmeasured or self-reported, these data
are essential to the quality and applicability of
cancer-related clinical trials.
TBM page 83 of 88ever-increasing amount of data. This problem is
exacerbated by the need in CER to merge these
data with information from other sources such as
medical records, physiological monitors, and
patient self-reports.
CER, with its emphasis on overall patient
outcomes and quality of life rather than short-
term biological or clinical endpoints, may stand to
beneﬁt greatly from more powerful approaches to
handle these data in health decision-making.
However, few models exist of systems designed
speciﬁcally to integrate and interpret the variety
of data important to cancer CER. This paper
provides an overview of one such system in
development, CYberinfrastructure for COmpara-
tive Effectiveness REsearch (CYCORE): improv-
ing data from cancer clinical trials and outlines
some of the challenges encountered in its initial
phases.
CYCORE is being developed by collaborators with
backgroundsinbehavioralscience,clinicalresearch,and
information technology (IT). It involves designing a
prototype of an IT system that supports the acquisition,
storage, visualization, analysis, and sharing of data
acquired within and across clinical trials. A particular
emphasis is being placed upon ensuring that CYCORE
has the ability to incorporate data from diverse sources,
in a variety of formats and over multiple studies, with a
special focus on acquisition of behavioral, lifestyle, and
environmental data. Since future studies might gather
data that are now unanticipated, the infrastructure for
CYCORE must be scalable, easily modiﬁed, and
adaptable to changing requirements, data structures,
maintainability, and governance.
Figure 1 shows a simpliﬁed view of the CYCORE
system and how stakeholders will interact with it.
Stakeholder categories include research participants
(e.g., cancer patients or survivors, family members,
and community members), researchers and research
teams, oncologists and other health-care providers,
resource providers (including tool developers and
medical data providers), operators, and policy makers.
The aim is to serve researchers and health-care
providers through a system that supports (1) data
collection, assimilation, and quality assurance from
existing data sources (e.g., electronic medical records)
and emerging data sources (sensor measurements and
self-reports), (2) data distribution and event notiﬁcation
for use by researchers, clinicians, policy makers, and
operators of the cyberinfrastructure (CI), (3) data
analysis and visualization capabilities, and (4) governed
service and resource integration to address security and
privacy concerns.
Development of CYCORE is centered on ﬁve
areas of effort:
1) Obtaining system requirements from cancer
researchers, clinicians, and patients.
To ensure that CYCORE is easily usable and can be
integrated into current CER, requirements and prefer-
ences are being gathered from clinicians, researchers,
resource providers, and research participants. This
includes compiling information about speciﬁc health-
related states that require monitoring, and the methods
for doing so. Requirements have been deﬁned in the
context of speciﬁc use-cases that are based on actual
research protocols. In addition to information about
sources of data, requirements are being gathered about
the forms of analyses that are needed and for what
purposes (e.g., intervention or generation of reports),
the appearance and functionality of patient and
provider interfaces, how the resources are managed,
the activities the system should support, and data-
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Fig 1 | CYCORE scenario. Data from patient self-reports and body-worn sensors (interacting with the Home Health Hub, see
below), complemented by ﬁxed sensors in the environment, can be collected and analyzed (using, for example, Brain-Based
Devices) to perform Comparative Effectiveness studies
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mation Portability and Accountability Act require-
ments, etc.).
Stakeholders were identiﬁed from a single institu-
tion (MDACC) using both purposeful and snowball
sampling methods. To date, requirements have been
collected from 61 stakeholders representing most of
the key stakeholder categories identiﬁed a priori for
CYCORE, including research investigators and
research staff (n=20), oncology physicians, and other
health-care providers (n=16), administrators and
policy makers (n=10), and informatics/IT experts
(n=15). The methodology for requirements elicitation
followed an iterative process identifying stakeholder
roles, their goals, their activities and the context in
which they operate, limitations in the current proto-
cols, features expected from the CYCORE system
(e.g., data acquisition from patient sensors), and
quality-of-service requirements (e.g., usability, port-
ability, and reliability). The methodology employed
domain modeling (see Figs. 2 and 3), i.e., creation of
models depicting issues of particular importance for
any given type of cancer and its treatment, and their
relationships. Establishing a common understanding
and language is key for eliciting requirements and
involves acquiring domain knowledge, observing the
environment, and establishing trust relationships with
all parties.
User scenarios were detailed by the stakeholders,
showing how each would interact with the system to
achieve a particular goal (e.g., how a researcher wants
to design and monitor a study, how a patient would
like to follow his or her progress in regard to speciﬁc
monitoring outcomes, etc.). In addition to require-
ments from researchers and clinicians, several meet-
ings were held with providers of electronic solutions
for existing medical and research data, with the goal
of deﬁning integration points with CYCORE.
The requirements-elicitation process is iterative.
Thus, an initial list of requirements was identiﬁed,
which advances the architecture of the system and
the implementation of a prototype, and then a new
set of requirements and reﬁnements is generated via
multiple feedback loops. New requirements were
then reviewed and prioritized so as to include them
in the next iteration of the prototype, and enables
validation of their implementation. This iterative
process for requirements engineering helps reduce
the risks of designing an inadequate system or of
over-engineering.
Several themes have emerged from these
exchanges including the need for CYCORE to (1)
convey frequently updated symptom assessment and
intervention-adherence feedback to clinicians and
researchers, (2) automate the collection of question-
naire-type dietary and quality-of-life data, (3)
provide algorithms for analysis and validation of
data from multiple sensors (e.g., the integration of
information from global positioning systems and
accelerometers as a measure of physical function-
ing), (4) integrate institutionally established ontolo-
gies with more globally accepted structures (e.g.,
the cancer Biomedical Informatics Grid [caBIG]),
and (5) continually reevaluate what is doable versus
what cannot be accomplished given institutional and
technology-related constraints.
2) Creating a system that enables multi-format data
aggregation, integration, processing, mining, stor-
age and retrieval.
CYCORE is leveraging systems-level data inte-
gration, processing, mining, and storage technolo-
gies that are already being developed by
collaborators from UCSD’sC a l i t 2a n dS a nD i e g o
Supercomputer Center, with support from the
National Science Foundation, the NIH, and others.
These are being further enhanced to deal with the
speciﬁc data types and application requirements
obtained from CYCORE’s initial panel of users.
CYCORE is being developed as open-source soft-
ware and will have a service-oriented “Rich
Fig 2 | Example of a domain model depicting a simpliﬁed view of a study
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integrate complex information obtained from a
variety of data types and sources, including elec-
tronic medical records, sensing and imaging devi-
ces, and other large-scale IT support systems in
oncology such as the caBIG.
CYCORE is a cyber-physical system, that is, a
system combining physical entities such as sensors
and mobile devices with processes such as data
acquisition, using an underlying computational and
data infrastructure (an integrated set of hardware
and software including user interfaces, middleware,
servers, and networks). This CI will provide
security, dependability, maintainability, scalability,
ﬂexibility, and other important properties. For
example, electronic medical systems have a set of
additional challenges related to data privacy, which
also must be addressed.
To facilitate the integration of system capabil-
ities and features into a scalable infrastructure,
CYCORE is being built as a service-oriented
architecture (SOA), a paradigm of software devel-
opment that provides “loose coupling” (i.e., weak
dependencies) between its various system services
(Fig. 4). Services are the mechanism by which
speciﬁc needs (e.g., a researcher’sn e e dt ov i s u a l -
i z ed a t ai naw e bb r o w s e r )a nd capabilities (e.g.,
obtaining data from two different sensors) are
Fig 3 | Example of a domain model depicting a simpliﬁed view of the Home Health Hub (HHH) sensor platform
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Fig 4 | Cyberinfrastructure (CI) interfaces and services. The CI will provide interfaces to sensors, data and storage resources,
and user applications. The CI provides core capabilities such as data acquisition, preservation, distribution, visualization,
and algorithm execution. The CI also manages crosscutting concerns such as policy and identity management within the
infrastructure
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[13]. Thus, the SOA approach promotes independ-
ent development and reuse of software compo-
nents that, in turn, reduce development cost.
SOAs provide the means to offer, discover, and
interact with CYCORE’s functions (e.g., acquiring
sensor data or storing and exporting data to
software packages normally used for CER out-
comes assessment).
All functional capabilities and resources are being
represented as services in the CYCORE system,
with precisely deﬁned service-access protocols.
Moreover, CYCORE uses a Rich Service Architec-
ture [8], which is a type of SOA for organizing
complex systems and managing distributed capabil-
ities that may be under the control of different
ownership domains. For example, with multiple
users, each institution may have its own policy for
the usage of its resources and data. Rich Services
allow for infrastructure services, such as policy
management (e.g., authorization, privacy, and audit-
ing) and identity management (authentication and
management of user identities), to be plugged into
the architecture without modifying core system
functionality. This feature ensures scalability, so
CYCORE can grow as new needs are identiﬁed,
and new users engage with the system without
changes to the underlying CI.
As described earlier and depicted in the ﬁgures,
CYCORE consists of physical resources such as
sensors, storage resources such as disks and net-
work drives, and larger servers necessary for high-
performance computing interfacing with increasingly
common “cloud computing”, data servers allocated
on-demand on shared infrastructures that are increas-
ingly offered by entities such as Microsoft and
Amazon. CYCORE also includes a research–partic-
ipant interface for the Home Health Hub (HHH)—the
physical device that integrates all patient data acquired
in the home—as well as tools and applications for
researchers. Data mining and analysis tools such as
Brain-Based Devices (see item 4 below) are applica-
tion modules that can be plugged into the infra-
structure as desired, through an application interface.
CYCORE poses data-related challenges that go
beyond traditional data-management systems includ-
ing: (1) end-to-end data preservation (long-term
storage of all data in the system) and access, (2)
management of associations between data collected
from various sources, but related to the same patient
(e.g., medical records, patient sensors, environ-
mental sensors, etc.), (3) execution of data-analysis
algorithms that themselves produce new data to be
ingested in the system and used by collaborators,
(4) complex event-based processing to detect cer-
tain events in the studies (such as detecting
dehydration risk in patients), and (5) time-stamping
of data as it is routed through the system. Further,
CYCORE addresses semantic heterogeneities across
data sources where, for example, different terms
may actually refer to the same concept [9].
Because the SOA disentangles infrastructure and
the applications that use it, policies no longer clutter
the speciﬁcations of each individual application.
Rather, they are off-loaded to and implemented in
the infrastructure itself, which then applies the policies
where and when needed in each application. This
leads to signiﬁcant ﬂexibility and scalability of the
system, as well as increased conﬁdence in the
adherence to policies: one only needs to go to a
single location in the architecture and the source code
to see whether a given policy is followed.
3) Building and/or integrating data-acquisition
hardware and software.
The primary interface between the research subject
and the CI will be provided via CYCORE’s HHH, to
which the biometric and environmental sensors trans-
mit data. Originally developed at Calit2, the HHH
aggregates sensor data and relays these to the
CYCORE data management system via a web-service
interface. The HHH consists of a small computer with
physical interfaces supporting radio-, serial- and USB-
enabled sensors. Thus far, monitoring capabilities of the
HHH via wireless devices include blood pressure,
weight, physical activity, photo/video, environmental
tobacco smoke, and medication adherence via “smart
pill bottles.”
The HHH enables two-way communication
between patients and researchers through audio and
video feeds and can support interfaces such as touch-
screens on which questionnaires for self-report data
can be displayed. CYCORE collects data in sensor
streams that are compatible with those from other data
sources important to cancer CER, such as clinical
records and lab data. Within the last 18 months, there
has been a rapid increase in the range and extent of
inexpensive sensors of all types that can be deployed
via wireless connection to the HHH. Also, several
systems that have some of the features of the HHH
have come on the commercial market. Evaluation of
how these systems might support CYCORE is
presently underway.
4) Data analysis with a “Brain-Based Device” ana-
lytic system.
Collecting data on patient treatments and out-
comes must be matched with a strong ability to
compile and interpret the wide range of variables
that must be considered in the cancer treatment.
One of the most innovative elements of CYCORE
will be to explore the use of a Brain-Based Device
(BBD) to assist with the processing and interpreta-
tion of the complex data sets collected in CER
studies. BBDs were developed at the Neurosciences
Institute of La Jolla under the direction of Nobel-
laureate Gerald Edelman [10–12]a n dw e r et h e n
advanced from concept to desktop implementation
by the Intellisis Corporation in conjunction with
Calit2 researchers. BBDs are beginning to change
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processed through use of a neurobiology-inspired
approach to information analysis, categorization,
and correlation because they have the unique ability
to accept missing and corrupted data without
disturbing the primary “learning” trends in the data
mining, and have been utilized successfully in
robotics and smart systems.
The advantage that BBDs have over traditional
statistical data-mining techniques is their ability to
comprehend, model, and make inferences from very
largenumbersofdata inputs andoutputs.CYCORE will
explore the use of a BBD to emulate the responses of
patients to cancer treatments. Variables will include
those that relate to patient history, cancer treatment, and
behavioral and environmental factors in the course of
treatment. Through “computer training” of the BBD, we
will attempt to model patients’ responses and thus
predict the success of future courses of treatment. While
this 2-year project will not be able to incorporate this
technology to its fullest extent, evaluation of its
feasibility and usability in this project will set the stage
for future studies.
5) Conducting pilot studies of the use of CYCORE.
After developing the ﬁrst (stripped-down) iteration
of CYCORE, we will assess its functionality and ease-
of-use use by testing data from a sample of cancer
survivors and their caregivers or family members.
Through ongoing feasibility testing, we will evaluate
the processes of data collection, transfer, and integra-
tion. Simple web interfaces will be customized for
various stakeholder groups (patients, cyber-operators,
policy makers, and researchers). Information gleaned
from this evaluation will enable improved iterations
with increasing functionality and permit us to plan the
course of subsequent stages of development.
Exploiting existing resources for evaluating user-
centered designs (e.g., www.usability.gov), we will
establish milestones for determining feasibility, such
as patients’ responses to prompts for self-reported
data, activation and communication of home- or
personal monitoring equipment, patient adherence to
procedures for self-monitoring and/or self-reported
data capture, successful uploading and storage of data,
and ability to search and access data for analysis.
Outcomes will be assessed objectively according to
customary protocols. Field staff will also conduct
debrieﬁng interviews with participants to assess their
experiences using the HHH suite of devices and to
troubleshoot any problems or barriers to their use that
might arise. Data collected in the debrieﬁng will
immediately be summarized and reported to the
investigators to ensure rapid problem resolution.
CONCLUSION
The vision for the CYCORE project is to develop a
prototype of a comprehensive, state-of-the-art IT-
based system to enable large-scale and robust CER
across the cancer continuum, i.e., from cancer
prevention to cancer treatment and ultimately, to
cancer control and survivorship care. The need for
such an infrastructure is great given the complexities
inherent in the prevention and treatment of cancer.
To be most meaningful, questions in CER should be
informed by not only medical and clinical data but
data from other domains critical to health such as
behaviors and the everyday experiences of individ-
uals in their home environment. Subsequent reports
from this project will provide further insight into
how to accomplish this and should guide others as
they endeavor to translate research into practice and
improve patient and population-level outcomes.
Acknowledgements: This study is supported by the National Institutes
of Health (National Cancer Institute), grant # RC2CA148263-01.
Open Access: This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any non-
commercial use, distribution, and reproduction in any medium, provided
the original author(s) and source are credited.
1. DHHS (U.S. Department of Health and Human Services) (2009).
Federal Coordinating Council for Comparative Effectiveness
Research. Report to the President and Congress. 30 Jun 2009.
2. Gritz, E. R., Dresler, C., & Sarna, L. (2005). Smoking, the missing
drug interaction in clinical trials: ignoring the obvious. Cancer
Epidemiology, Biomarkers & Prevention, 14, 2287–2293.
3. Bairati, I., Meyer, F., Jobin, E., et al. (2006). Antioxidant vitamins
supplementation and mortality: A randomized trial in head and
neck cancer patients. International Journal of Cancer, 119,
2221–2224.
4. Chlebowski, R. T., Aiello, E., & McTiernan, A. (2002). Weight loss
in breast cancer patient management. Journal of Clinical
Oncology, 20, 1128–1143.
5. Holmes, M. D., Chen, W. Y., Feskanich, D., Kroenke, C. H., &
Colditz, G. A. (2005). Physical activity and survival after breast
cancer diagnosis. JAMA, 293, 2479–2486.
6. Meyerhardt, J. A., Heseltine, D., Niedzwiecki, D., et al. (2006).
Impact of physical activity on cancer recurrence and survival in
patients with stage III colon cancer: ﬁndings from CALGB 89803.
Journal of Clinical Oncology, 24, 3535–3541.
7. Velicer, C. M., & Ulrich, C. M. (2008). Vitamin and mineral
supplement use among US adults after cancer diagnosis: a
systematic review. Journal of Clinical Oncology, 26, 665–673.
8. Arrott, M., Demchak, B., Ermagan, V., Farcas, C., Farcas, E.,
Krüger, I. H., et al. (2007). Rich services: the integration piece of
the SOA puzzle, in proceedings of the IEEE International Confer-
ence on Web Services (ICWS) (pp. 176–183). Salt Lake City,
Utah, USA: IEEE.
9. Baru, C., & Lin, K. (2009). Mediating among GeoSciML resources.
In International Journal of Digital Earth (pp. 18–28). London:
Taylor & Francis.
10. Krichmar, J. L., & Edelman, G. M. (2005). Brain-based devices for
the study of nervous systems and the development of intelligent
machines. Artiﬁcial Life, 11,6 3 –77.
11. Edelman, D. B., Baars, B. J., & Seth, A. K. (2005). Identifying
hallmarks of consciousness in non-mammalian species. Con-
sciousness and Cognition, 14, 169–187.
12. Seth, A. K. (2005). Causal connectivity of evolved neural
networks during behavior. Network, 16,3 5 –54.
13. OASIS Reference Model for Service Oriented Architecture 1.0
http://docs.oasis-open.org/soa-rm/v1.0/soa-rm.pdf, 2006
CASE STUDY
TBM page 88 of 88